Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Report: Medtronic readies $10B bond flotation for Covidien deal
Mass Device
Monday, November 17, 2014 - 10:58am
tags:
Medtronic, Covidien, M&A, devices
Neuro Kinetics wins NFL grant for brain-injury detector
Mass Device
Monday, November 17, 2014 - 10:56am
tags:
Neuro Kinetics, brain injury, NFL, grants, I-Portal PAS, devices
Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Seeking Alpha
Monday, November 17, 2014 - 10:55am
tags:
Eliquis, bloodthinners, Adexanet Alfa, Portola Pharmaceuticals, Pfizer, Bristol-Myers Squibb
Gilead: What About Its Pipeline?
Barron's
Monday, November 17, 2014 - 10:52am
tags:
Gilead Sciences, hepatitis C
[video]Actavis CEO: Huge commitment to R&D
CNBC
Monday, November 17, 2014 - 10:50am
tags:
Actavis, Allergan, M&A, R&D, Brent Saunders, David Pyott
Zoetis Buys Abbott’s Animal Health Assets in $255 Million Deal
Bloomberg
Monday, November 17, 2014 - 10:17am
tags:
Zoetis, Abbott Labs, animal health, M&A
Pharmaceutical giant Actavis to buy Botox maker Allergan for $66 billion in cash-and-stock
Yahoo/AP
Monday, November 17, 2014 - 10:01am
tags:
Actavis, Allergan, M&A
Valeant says can't justify matching Actavis bid for Allergan
Yahoo/Reuters
Monday, November 17, 2014 - 9:43am
tags:
Valeant Pharmaceuticals, Actavis, Allergan, M&A
Roche's Avastin Should Get The Nod From The FDA On November 19
Seeking Alpha
Monday, November 17, 2014 - 9:04am
tags:
Roche, Avastin, FDA
After Years Under Attack, Merck's Vytorin Proves Effective
Forbes
Monday, November 17, 2014 - 9:03am
tags:
Merck, Vytorin
Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer
Yahoo
Monday, November 17, 2014 - 8:55am
tags:
Actavis, Durata Therapeutics, M&A
Reckitt Benckiser to spin-off drug unit into new listing
Telegraph, UK
Monday, November 17, 2014 - 8:36am
tags:
Reckitt Benckiser, spinoffs
No safety concerns yet in trials of GSK's Ebola vaccine
Yahoo/Reuters
Monday, November 17, 2014 - 8:34am
tags:
GSK, ebola virus, clinical trials, vaccines
[video]Merck KGaA Won't Play Part in Consolidation, Kley Says
Bloomberg
Monday, November 17, 2014 - 8:33am
tags:
Merck KGaA, Pfizer, cancer immunotherapy, MSB0010718C
AstraZeneca lupus drug produces positive results in trial
Yahoo/Reuters
Monday, November 17, 2014 - 8:31am
tags:
AstraZeneca, lupus, Benlysta, sifalimumab
Pfizer to Buys Merck KGaA Cancer Drug Rights
Bloomberg
Monday, November 17, 2014 - 7:06am
tags:
Pfizer, Merck KGaA, cancer immunotherapy, MSB0010718C
Allergan, Actavis near deal; announcement as soon as Monday-source
Reuters
Monday, November 17, 2014 - 7:05am
tags:
Allergan, Actavis, M&A, Valeant Pharmaceuticals
Medtech mergers stayed strong in Q3
Ortho Spine News
Saturday, November 15, 2014 - 9:55am
tags:
M&A
Merck Serono Plans to Make China Leader in Oncology Treatment
Yibada, China
Saturday, November 15, 2014 - 9:53am
tags:
Merck Serono, China
DOJ Investigation into Generic Pharmaceutical Pricing Signals Potential Criminal Exposure
law.com
Saturday, November 15, 2014 - 9:46am
tags:
generics, legal

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.